Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading PAVmed Inc chart...

About the Company

pavmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and efficiency. led by three accomplished medical device entrepreneurs and organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs, our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency.

Exchange

NASDAQ

Website

http://www.pavm.com/

$2M

Total Revenue

57

Employees

$25M

Market Capitalization

-0.31

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PAVM News

PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript

15h ago, source:

Q4 2023 Earnings Call March 27, 2024 PAVmed Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)

15h ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PAVmed (PAVM – Research Report) and ...

New Strong Buy Stocks for March 27th

Opinion ago, source: Zacks.com on MSN

List today:Royal Caribbean Cruises Ltd. RCL: This cruise company has seen the Zacks Consensus Estimate for its current year ...

PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX

8d ago, source: Stockhouse

The incubator, PMX, and medical device firm Hatch Medical, execute joint venture agreement to complete their development and commercialization, starting with PortIO NEW YORK, March 21, 2024 ...

PAVmed Inc.: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results

1d ago, source: Finanznachrichten

Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio technologies Conference call and webcast to be held tomorrow, March 27 th at 8:30 AM ET NEW ...

PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q4 2023

1d ago, source:

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PAVmed (NASDAQ:PAVM) just reported results for the fourth quarter of ...

PAVmed (NASDAQ: PAVM)

6d ago, source: The Motley Fool

PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices ...

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

on MSN ago, source:

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary ...

PAVmed Inc. (1P50.F)

28d ago, source: Yahoo Finance

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ( ...

Q4 2023 PAVmed Inc Earnings Call

23h ago, source:

Ed Woo; Analyst; Ascendiant Capital Markets LLC Nick Sherwood; Analyst; Maxim Group LLC ...

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results

2d ago, source: Yahoo Finance

Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio technologies Conference call and webcast to be held tomorrow, March 27 th at 8:30 AM ET NEW ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...